YahooAugust 13, 2026 at 9:35 AM NY22 days ago

Inside Latigo Biotherapeutics’ IPO: A Non-Opioid Pain Bet Goes Public

A California biotech just raised $350 million promising to out-perform opioids without the addiction risk, and its auditors were still warning about survival just months ago. Here is what the science and the filings actually show.

Read the Full Story at the Source

The summary here comes from the news provider; the rest of the article lives on the publisher's site — Yahoo

Read at Source

Companies in This Story

VRTXVertex Pharmaceuticals Inc545.15− 2.30%

Companies in This Story

Related Stories